ELISA based Diagnosis of Neurodegeneration
These easy-to-handle and ultrasensitive immunoassays provide improved diagnosis for Alzheimer’s, Parkinson’s, and Creutzfeldt-Jakob disease. They use recombinant proteins and rapidly generating monoclonal antibodies unique to a variety of biomarkers.
The most common form of dementia, Alzheimer’s disease (AD) is a progressive neurodegenerative disorder. AD affects more than 36 million people worldwide and occurs most commonly in Western Europe. Our solutions:
The hallmark of Parkinson’s disease is the presence of Lewy bodies in subcortical brain regions. Lewy bodies are deposits made of aggregated and phosphorylated α-synuclein. Our solutions:
The third area in this profile focuses on differential diagnostics for rapid-onset Creutzfeldt-Jakob disease (CJD). This disease is caused by the aggregation of cellular prion protein. Human prion disorders are rare and only affect one to two cases per million people.